| Trial ID: | L7169 |
| Source ID: | NCT06127433
|
| Associated Drug: |
Insulin Glargine
|
| Title: |
The Effect of Short-term Insulin Intensive Therapy Based on the Application of Insulin Pump and Real-time Dynamic Glucose Monitoring Technology on Reversing the Newly Diagnosed Type 2 Diabetes
|
| Acronym: |
|
| Status: |
RECRUITING
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Insulin Pump，Continuous Glucose Monitoring Technology
|
| Interventions: |
DRUG: Insulin Glargine|DRUG: Metformin|DRUG: Dapagliflozin|DRUG: Insulin aspart
|
| Outcome Measures: |
Primary: Intergroup remission rate at 24 week, Fasting blood glucose\<7mmol/L, and glycated hemoglobin\<6.5%, 24 week |
|
| Sponsor/Collaborators: |
Sponsor: Sun Yat-sen University
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
210
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2023-03-07
|
| Completion Date: |
2024-12-30
|
| Results First Posted: |
|
| Last Update Posted: |
2023-11-13
|
| Locations: |
刘烈华, Guandong, China
|
| URL: |
https://clinicaltrials.gov/show/NCT06127433
|
